What's new

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised

Feb 10, 2025 - 17:52
 0
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised
Read More

Tags:

Previous Article

Novartis debuts €40M viral vector plant in Slovenia, part of €3.5B investment pu...

Next Article

Leading Philippines EV Company Energizes More Charging Stations, Launches Member...

Related Posts

Herbal medicinal product: Boldi foliumArray, C: ongoing call for scientific data

Herbal medicinal product: Boldi foliumArray, C: ongoing...

Feb 11, 2025  0

Opinion on medicine for use outside EU: Ivermectin/Albendazole, ivermectin,albendazole, Parasitic Diseases,Helminthiasis,Hookworm Infections,Ascaridida Infections,Trichuriasis,Strongyloidiasis, 30/01/2025 Positive opinion

Opinion on medicine for use outside EU: Ivermectin/Albe...

Mar 18, 2025  0

European Medicines Agency's data protection notice on t...

Mar 12, 2025  0